How Big Pharma Markets to and Profits from a 'Can't-Pay-Attention Nation' [1]

Common Dreams, By: Jon Queally, 12/16/2013

What came first: the disorder, the cure, or the marketing campaign to sell both? In the case of medicating a generation of children who were said to be "unusually hyperactive," the answer to that question is addressed by an in-depth investigation by the New York Times on Monday showing that the meteoric rise of diagnoses of attention deficit hyperactivity disorder (A.D.H.D.)—a trend that spawned a pharmaceutical gold rush over the last twenty years—was, in fact, fueled by an industry-led marketing campaign that targeted struggling children, worried parents, and an army of doctors willing to diagnose and prescribe. And what's worse? The deep-pocketed, pill-pushers are now looking to expand.

 

For more on this story visit www.commondreams.org [2]